The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biochemical, pathologic, toxicity, and quality-of-life outcomes in a five-fraction hypofractionated accelerated radiotherapy treatment using standard linear accelerators and gold seed fiducials.
D. Andrew Loblaw
No relevant relationships to disclose
Patrick Cheung
No relevant relationships to disclose
Colin I Tang
No relevant relationships to disclose
Harvey Charles Quon
No relevant relationships to disclose
Geordi Pang
No relevant relationships to disclose
Gerard Morton
No relevant relationships to disclose
Alexandre Mamedov
No relevant relationships to disclose
Laura D'Alimonte
No relevant relationships to disclose
Andrea Deabreu
No relevant relationships to disclose
Romeo Tirona
No relevant relationships to disclose
Suneil Jain
No relevant relationships to disclose